Summary. The effect of acute arterial blood pressure lowering upon albumin extravasation was studied in 10 patients with nephropathy and retinopathy due to long-standing Type I (insulin-dependent) diabetes. The following variables were measured: transcapillary escape rate of albumin (initial disappearance of intravenously injected ~2SI-labelled human serum albumin), and urinary albumin excretion rate (radial immunodiffusion). The study was performed twice within 2 weeks, with the patients receiving an intravenous injection of either clonidine (225 txg) or saline (0.154 mmol/1). The clonidine injection induced the following changes: arterial blood pressure decreased from 134/87 to 107/73 mmHg 6o<0.01), transcapillary escape rate of albumin declined from 8.1 to 6.7% of the intravascular mass of albumin/h (p < 0.01), albuminuria diminished from 1434 to 815 ~tg/min (p<0.01), and plasma volume raised slightly from 2916 to 2995 ml (p<0.05). Our findings demonstrate that the enhanced albumin passage through the wall of the microvasculature characteristically found in long-term Type 1 diabetic patients with clinical microangiopathy is pressure-dependent to a large extent. This may be due to elevated hydrostatic pressure in the microcirculation.
Transcapillary escape rate of albumin (TERalb, defined as the fraction of intravascular mass of albumin that passes to the extravascular space per unit of time) is elevated in newly diagnosed and short-term Type I (insulin-dependent) diabetic patients with poor metabolic control [1, 2] . This abnormality is normalized during strict metabolic control [1, 2] . Elevated hydraulic pressure in the microcirculation has been suggested as an explanation for this reversible phenomenon [1] . The enhanced TERalb characteristically found in long-term Type 1 diabetic patients with clinical microangiopathy is not affected by metabolic control, suggesting a per se effect of the microvascular lesions on albumin extravasation [2] [3] [4] . In addition, haemodynamic factors, e.g. elevated capillary hydrostatic pressure, may be involved. It is well documented that acute and chronic arterial and venous hypertension enhance TERalb [5] [6] [7] [8] .
Recent studies have suggested a link between capillary hypertension, increased extravasation of plasma proteins and the development and progression of diabetic microangiopathy [9] [10] [11] .
To elucidate this haemodynamic concept, we investigated the effect of acute blood pressure reduction on TERalb and albuminuria in Type 1 diabetic patients with nephropathy.
Subjects
Ten Type I diabetic patients with nephropathy were investigated ( Table 1 ). The present and a previous study dealing with autoregulation of glomerular filtration rate [12] were carried out during the same series of experiments. All patients were insulin-dependent from the time of diagnosis, and all received two daily injections of insulin. Apart from insulin, none of the patients were taking any other drugs. Diabetic nephropathy was diagnosed clinically according to previously described criteria [13] . Furthermore, a kidney biopsy had been performed in all patients except patient 1. Nodular diabetic glomerulosclerosis was found in two patients, while diffuse diabetic glomerulosclerosis was demonstrated in the remaining seven patients.
All patients gave their informed consent, and the experimental design was approved by the local Ethical Committee.
Methods
The study was performed twice within 2 weeks, with the patients receiving a slow intravenous injection (10min) at 8,40 hours of either clonidine (2251xg, Boehringer, Ingelheim, FRG) or saline (0.154 mmol/1), in random order. Measurements were taken in the morning following an overnight fast. The study was carried out from 09.00 to 13.00hours. The patients had their last injection of insulin at 17.00 hours the day before the study. The patients drank 200 ml of tapwater per hour during the study. Measurements were performed in the supine position. Glomerular filtration rate (GFR) was measured after a single intravenous injection of 51Cr-EDTA (09.00 hours) by studying the plasma disappearance for 4 h, as described by Br6chner-Mortensen et al. [14] . Urinary albumin excretion was measured during the 4-h clearance period using the radial immunodiffusion technique [15] .
Transcapillary escape rate of albumin is defined as the fraction of intravascular mass of albumin that passes to the extravascular space per unit of time. It is determined as the rate constant of the practically monoexponential decrease in plasma radioactivity over the first 60 min after injection of tracer albumin (initial slope method), as calculated by the least squares method. We have described this procedure and the theoretical basis for the calculation of TERalb in detail previously [5, 16] . Briefly, human serum albumin labelled with usI (code MIAK, Institute of Atomic Energy, Kjeller, Norway) was injected intravenously at 12.00 hours. The tracer preparation contains less than 1.0% of free radioactive iodide and has by metabolic studies been demonstrated to behave like endogenous albumin [17] . About 6 ,uCi of the tracer was injected into one arm vein, and 9 venous blood samples of 6 ml each were drawn from the other arm, 10,15, 20, 30, 35, 40, 50, 55, 60 rain after the injection. Plasma protein concentration was read refractometrically in duplicate with a total solid-meter (American Optical Corp., Scientific Instrument Div., Buffalo, NY). None of the patients had interfering hyperlipemia. The plasma radioactivity was expressed as cpm/g total plasma protein to cancel out the effects of small plasma volume change during the 1-h sampling period.
The mean intra-individual coefficient of variation for TERalb is 8.5% [6] . The normal value of TERalb (adults) in our laboratory is 5.4 • 1.1 % of the intravascular albumin mass (mean + SD) [16] .
Plasma volume was determined by extrapolation of the disappearance curve of tracer albumin to injection time, and from the injected amount of tracer measured by weighing. The mean intra-individual coefficient of variation for plasma volume in our laboratory is 1.5% [6] .
Plasma albumin concentration was measured at the start of each TER determination by the method of Laurell [18] . Intravascular mass of albumin (IVMalb) equals plasma volume • plasma concentration of albumin. Blood glucose was measured every hour during the 4-h investigation period by a glucoseoxidase method on an autoanalyzer (Model ]I, Technicon, Tarrytown, New York, USA). Stable haemoglobin Alo was measured at the first investigation (normal range 4.1 to 6.1% of total haemoglobin) [19] . Blood pressure was measured with a centration decreased slightly during the course of the 4h investigation period (Table3). Apart from a dry mouth and sleepiness, no serious side-effects were observed after clonidine.
Statistical analysis
The paired (diabetic patients) and the unpaired (diabetic patients and control subjects) Student's t-test (two-tailed) was used. A two-way analysis of variance was used for analysis of the blood pressure values.
Results
None of our patients had frank hypertension, but borderline hypertension was present in 3 patients (nos. 7, 8, 9). The clonidine injection reduced arterial blood pressure from 134/87 + 8/3 to 107/73 + 11/5 mmHg (Table2, p <0.01). The blood pressure reduction remained stable during the 4-h clearance-procedure (Table 3) . TERalb declined in all patients following the clonidine injection, from 8.1+1.4 to 6.7+1.6% IVMalb/h (Table 2, p < 0.01). The TERalb values before and after clonidine injection are elevated compared to healthy adults (n--28), mean 5.4+1.1% IVMalb/h (p<0.05) [16] . There were no significant changes in total plasma protein concentration during the TERalb determination (60 min), either before, mean 60.1_+6.1g/1 (10-15min) and 60.2+6.2g/1 (55-60 min), or after the clonidine injection, mean 58.4_+ 6.2 g/1 (10-15 rain) and 57.5 _+ 5.4 g/1 (55-60 min). Plasma volume increased in 8 out of the 10patients (mean 2.7%) after clonidine ( Table 2 , p < 0.05). Plasma albumin concentration remained practically unaltered. A slight, but statistically insignificant, increase in IVMalb was found after clonidine (mean 4.8%). Albuminuria diminished in all patients from a mean of 1434 + 816 to 815 + 459 ~tg/min after clonidine (p < 0.01). The blood pressure reduction following clonidine induced a decline in GFR from 81 _+ 21 to 73 + 21 ml/ min/1.73 m 2 (p < 0.01).
Blood glucose during the TERalb measurements, was slightly higher during the control studies (mean 12.8 + 4.6 mmol/1) compared with the clonidine studies (mean 10.6 _ 6.2 mmol/1), (p > 0.1), Blood glucose con-
Discussion
Our study has demonstrated diminished transcapillary escape rate of albumin and albuminuria during acute arterial blood pressure reduction in normotensive and in borderline hypertensive Type 1 diabetic patients with nephropathy. Since the transglomerular fraction of the overall albumin extravasation rate constitutes maximally a few percent, our study demonstrates that the reduced extravasation of albumin, as measured by TERalb, occurs mainly in the microvasculature of the extrarenal organs.
Poor metabolic control enhances TERalb and urinary albumin excretion in short-term Type I diabetic patients without clinical microangiopathy [1] . Strict metabolic control normalizes these abnormalities [1] . Neither short-term nor long-term strict metabolic control induces a reduction in albuminuria in Type 1 diabetic patients with diabetic nephropathy [20, 21] . O'Hare et al. [2] found no relation between the elevated TERalb and mean blood glucose or HbAt levels in Type I and Type 2 diabetic patients with microangiopathy. Furthermore, one year of strict metabolic control obtained by continuous subcutaneous insulin infusion has failed to influence the abnormally elevated TERalb found in 18 Type I diabetic patients with microangiopathy (Bo Feldt-Rasmussen, personal communication).
Finally, insulin has no effect on TERalb in Type 1 diabetic patients [221. Thus, it seems highly unlikely that the present small difference in metabolic control in our study had any impact on TERalb and albuminuria measured during the 4-h clearance procedure.
The mechanisms involved in the abnormally elevated microvascular passage of albumin characteristically found in long-term Type I diabetic patients with microangiopathy can either be an increase in the permeability (charge-size selective filter properties) and/or a raised hydrostatic pressure gradient across the microvascular wall. A loss of the charge selective properties and increased pore size of the glomerular capillary wall con-tribute to albuminuria in diabetic nephropathy [23, 24] . Studies in diabetic animals have suggested a decreased rate of synthesis of acid glycosaminoglycans in the renal and extra-renal microvasculature [25] [26] [27] .
Direct measurements of nail fold capillary pressure revealed normal values in a group of Type 1 diabetic patients with and without clinical microangiopathy [28] . Direct determination of glomerular pressure in insulintreated streptozotocin diabetic rats has revealed glomerular hypertension [29, 30] . A marked elevation in glomerular capillary hydrostatic pressure, 52.6versus 43.8 mmHg, has been found in spontaneous hypertensive diabetic rats compared to non-diabetic hypertensive rats (mean arterial blood pressure 160 mmHg) [31] .
that the albumin leakage found during normal conditions is not pressure-dependent.
From the present observations it is suggested that the rapidly reversible part of the elevated TERalb and alburninuria cannot be explained by concomitment changes in the permeability (morphological origin, microangiopathy) but is probably due to a reduction in the hydrostatic pressure of the microcirculation (haemodynamic origin). If a link between capillary hypertension, increased extravasation of plasma proteins and the development and progression of diabetic microangiopathy exists, as previously suggested [9] [10] [11] , our results support the case for an early and effective treatment of arterial blood pressure elevation.
Our study suggests that the enhanced albumin passage through the wall of the microvasculature is pressure-dependent to a large extent. The most simple explanation of our findings may therefore be the correct one: a reduction of the hydrostatic pressure in the microcirculation induced by acute lowering of systemic blood pressure. If elevated hydrostatic pressure is present in the microcirculation as suggested, it is not a consequence of arterial hypertension, since seven of our patients were normotensive and only three had borderline hypertension. Furthermore, moderate blood pressure elevation (mean 144/98 mmHg) does not enhance TERalb (mean 5.7% IVMalb/h) in patients with essential hypertension [32] .
Normally, glomerular filtration rate and blood flow to various organs and tissues are kept relatively constant in response to rather wider variations in perfusion pressure; this phenomenon is termed autoregulation. Several studies have demonstrated impaired autoregulation of blood flow to the brain, eyes, skeletal muscle and subcutaneous tissue in long-term Type 1 diabetic patients with clinical microangiopathy [33] [34] [35] [36] . We have previously demonstrated impaired autoregulation of GFR in the presently studied patients [12] . Impaired autoregulation, particularly in case of a complete pressure-passive vasculature, will contribute significantly to the present findings due to hypoperfusion and hypotension in the microcirculation.
The slight increase in plasma volume and in intravascular albumin mass is probably due to reduced filtration from the intra-to the extravascular space. In this context, it should be mentioned that acute hypertension induced by intravenous infusion of angiotensinlI causes exactly the opposite effects: increased TERalb, reduced plasma volume and intravascular albumin mass [6] . Elevated TERalb and urinary albumin excretion rate are present in essential hypertension, and both variables can be normalized during antihypertensive treatment [16, 37] . Acute reduction in mean arterial blood pressure of 16 to 18 mmHg, induced by intravenous injection of clonidine, has no effect on the normal urinary albumin excretion rate in short-term Type I diabetic patients and in control subjects [12] . This suggests
